Viewing nowCombinationDucal Tablet 60/5 mg
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.

MFDS item code 202300097 · Approved 2023.01.06 · Insurance code 647304490
Treatment of essential hypertension not controlled by fimasartan monotherapy
Pimasartan potassium is used in the treatment of essential hypertension and can be used as an adjunct therapy when blood pressure is not adequately controlled with monotherapy, helping to manage blood pressure more effectively.
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted with fimasartan before administering this medicine. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams alone. ㆍ 60/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams alone. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams alone or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in children and adolescents aged 18 years or younger.
This medication may pose a risk of serious harm or death to the fetus and newborn if taken during pregnancy, particularly in the second and third trimesters. Discontinue immediately if pregnancy is confirmed. Do not take this medication if you are allergic to any of the active ingredients or similar substances, if you are pregnant or nursing, if you are undergoing kidney dialysis, have moderate to severe liver disease, bile duct obstruction, specific kidney issues in diabetic patients, certain hereditary lactose intolerance, severe aortic stenosis, or in shock state. Patients with reduced blood volume or sodium levels, impaired kidney function, renal artery hypertension, aortic or mitral stenosis, primary aldosteronism, severe hypotension, elderly patients, and those allergic to specific pigments should exercise caution while using this medication. During treatment, side effects like dizziness, headaches, facial or peripheral edema, urinary disorders, insomnia, and flushing may occur; consult healthcare professionals if symptoms are severe or persistent. Regular blood tests and monitoring are needed due to possible hypotension, electrolyte imbalances, especially increased potassium levels. When combined with other antihypertensive medications, the blood pressure-lowering effect may increase or side effects may occur; inform healthcare professionals about other medications being taken. If you are pregnant or planning to become pregnant, consult healthcare professionals before taking this medication, and the same applies if you are breastfeeding. The safety and efficacy in children and adolescents under age 18 have not been established, so it is advisable not to use it. In the event of overdose, serious symptoms such as hypotension and cardiac arrhythmias may occur, requiring immediate emergency treatment. Store this medication out of reach of children and avoid transferring it to other containers to maintain quality and safety.
Dizziness, orthostatic dizziness, headache, facial edema, peripheral edema, urination disorder, insomnia, flushing, syncope, sedation, migraine, dyspepsia, vomiting, nausea, upper abdominal pain, asthenia, foreign body sensation, elevated liver enzymes, decreased platelet count, increased serum creatine phosphokinase, cough, muscle contraction, musculoskeletal stiffness, pruritus, localized urticaria, facial flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neuronitis, facial paralysis, normal pressure hydrocephalus, spinal canal stenosis, acute pancreatitis, intestinal obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, worsening cerebral infarction, cerebral hemorrhage, liver cancer, colorectal carcinoma, neoplasm of unspecified nature, cervical cancer, prostate cancer, acute renal failure, chronic renal failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, pulmonary fibrosis, pharyngitis, pneumonia, lung disease, death, worsening low back pain, osteoarthritis, arthropathy, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, hypertension, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, chest pain, low back pain, fatigue, fever, neck/shoulder pain, fracture, myalgia, pharyngitis, upper respiratory tract infection, sputum, rhinitis, epistaxis, bronchitis, paresthesia, numbness, tremor, excessive muscle tension, insomnia, depression, anxiety, memory impairment, decreased appetite, gastroesophageal reflux, gastritis, diarrhea, constipation, functional gastrointestinal disorders, dysuria, hyperlipidemia, dyslipidemia, frequent urination, urinary incontinence, hypertension, purpura, fatty liver, intestinal vessel edema after angiotensin II receptor antagonist use, abdominal pain, nausea, vomiting, diarrhea, flushing, fatigue, edema, palpitations, dizziness, drowsiness, abdominal pain, nausea, weakness, lethargy, pain, weight gain/loss, hypotension, vasculitis, tension enhancement, sensory loss, paresthesia, peripheral neuropathy, taste disturbance, tremor, extrapyramidal disorder, gynecomastia, change in bowel habits, dry mouth, dyspepsia, gingival hyperplasia, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, leukopenia, thrombocytopenia, insomnia, mood changes, cough, dyspnea, rhinitis, hair loss, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbance, increased frequency of urination, urination disorder, nocturia, hepatitis, jaundice, elevated liver enzyme levels, pruritus, rash, vascular edema, polymorphous erythema, myocardial infarction, arrhythmia, chest pain, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, epigastric pain, diarrhea, loose stools, constipation, skin erythema, maculopapular rash, heaviness, warmth sensation, decreased glucose tolerance, weakness
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that prevents light exposure. It is also recommended to store the medication at room temperature between 1 to 30 degrees Celsius to maintain its effectiveness.
Orange, rounded square film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.